Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated March 19, 2026.
Taking Stock: Market rally continues; Nifty near 24,200, Sensex gains 254 points
Biggest Nifty gainers were Max Healthcare, Interglobe Aviation, Trent, Bharat Electronics, Adani Enterprises, while losers included Infosys, Maruti Suzuki, Tech Mahindra, Tata Consumer and TCS.
Buy Niva Bupa Health Insurance; target of Rs 100: Motilal Oswal
Motilal Oswal recommended is bullish on Niva Bupa Health Insurance recommended buy rating on the stock with a target price of Rs 100 in its research report dated Jun 19, 2026.
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
Motilal Oswal recommended is bullish on Five Star Business Finance recommended buy rating on the stock with a target price of Rs 600 in its research report dated Jun 22, 2026.
Closing Bell: Nifty below 25,200, Sensex tanks 961 pts; realty, metal, FMCG top drag
Nifty Midcap and smallcap indices down 1% each. Dr Reddy's Labs, Bharti Airtel, M&M, HDFC Life, Sun Pharma were among the top drags on the Nifty, while gainers were Trent, HCL Tech, Infosys, Apollo Hospitals. Among sectors, auto, bank, FMCG, metal, realty, telecom shed 1-2%, while IT, media, consumer durables ended in the green.
Buy Star Health; target of Rs 700: Motilal Oswal
Motilal Oswal is bullish on Star Health recommended buy rating on the stock with a target price of Rs 700 in its research report dated Jun 25, 2026.
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated February 25, 2026.
Max Healthcare shares fall up to 7% as Q4 results miss estimates
Analysts at domestic brokerage Motilal Oswal Financial Services said the earnings miss was due to a higher tax rate .
Neutral Eris Lifesciences; target of Rs 1520: Motilal Oswal
Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 1520 in its research report dated February 14, 2026.
Neutral Lupin; target of Rs 2360: Motilal Oswal
Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2360 in its research report dated February 14, 2026.
Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal
Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 4300 in its research report dated February 14, 2026.
Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal
Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5525 in its research report dated February 14, 2026.